Geratherm Medical AG: Business performance from 1 January to 30 September 2020
Publication of an insider information pursuant to article 17 of MAR transmitted by DGAP - a service of EQS Group AG
Geratherm Medical AG, Geratal, November 12, 2020
Business performance from 1 January to 30 September 2020
- Continuing Strong international demand for Geratherm medical devices
- Sales revenues EUR 19.8 million +28.7 %, QIII +27.3 %
- Gross result for the period under review (EBITDA) EUR 3.053 million +43.5 %, ? ? QIII EUR 1.001 million +61.8 %
- Operating result (EBIT) EUR 2.140 million +71.6 %
??????????? QIII EUR 0.686 million +125.9 %
- EBIT margin 10.8 %, QIII +11.6 %
- Results from ordinary business activities EUR 2.054 million +64.9 %
??????????? QIII EUR 0.651 million +126.0 %
- Earnings per share EUR 0.31 (2019: EUR 0.15), QIII EUR 0.10
The business development of the Geratherm Medical AG continues to be very positive. In the III quarter, we managed to increase sales by 27.3 %. Our profits reported in the III quarter have more than doubled.
For the IV. quarter of the current financial year, we expect a significantly stronger sales and earnings performance compared to the previous year. The IV. quarter is likely to gain further momentum compared with the previous quarters. The capacities for the production of clinical thermometers are currently already fully utilized until July 2021.
The quarterly report on the 9-month financial statements will be published on November 19, 2020.
Geratherm Medical AG Firmensitz: Fahrenheitstra?e 1, 99331 Geratal Registergericht: Amtsgericht Jena, HRB 111272 Vorstand: Dr. Gert Frank Aufsichtsratsvorsitzender: Dipl.-Kfm. Rudolf Br?cker Tel. 036205/98 0; Fax: 036205/98 115 E-Mail: firstname.lastname@example.org
Short company profil: Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.
?Contact: Dr. Gert Frank
12-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Geratherm Medical AG Fahrenheitstra?e 1 99331 Geratal
Germany Phone: +49 (0)36205 98-0 Fax: +49 (0)36205 98-1 15 E-mail: email@example.com Internet: www.geratherm.com ISIN: DE0005495626 WKN: 549562 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1147785 ? End of Announcement DGAP News Service